sydunisportsmed
29-03-2005, 08:10 AM
Good opinion piece article in the BJSM this month, on the Kelli White case. Plenty of analogies with ADHD here, as this is a case where a number of US sprinters have been taking Modafinil, an amphetamine, and claiming they suffer from that terrible condition narcolepsy, where you fall asleep on the spot unless you happen to have popped an amphetamine.
The questions asked in the editorial are:
"Firstly, should modafinil be considered a psychostimulant? Secondly, if it is a psychostimulant, and yet is required to treat a medical condition, should the athlete be disqualified? Thirdly, how should one verify the alleged medical diagnosis? Fourthly, what must the athlete do in order to maintain eligibility to compete when on a "banned substance?" Fifthly, should the punishments be specific or should they be tailored to specific situations? Sixthly, are we witnessing further doping scandals? "
http://bjsm.bmjjournals.com/cgi/content/full/39/4/241
This paragraph says it all though:
"The prevalence of narcolepsy is only 0.02–0.05% in the United States. To have an elite athlete with narcolepsy would be rare; however, when the 2003 US Track and Field Championship urines were retested, a total of six athletes were reported positive for modafinil during 2003. Although Kelli White is the only athlete to state that she has narcolepsy, it is not surprising that the IAAF has scoffed at "a narcolepsy epidemic.""
None one has Level 1 scientific evidence to prove that you run faster with stimulants on board, but whether or not you do, a large number of US Track & Field sprinters are prepared to run the gauntlet of the drug code to try to get on it.
Do we really need to get psychiatrists and sleep experts to come up with guidelines for the diagnosis of ADHD and narcolepsy in elite athletes or shouldn't we just say that all amphetamines are banned? Let's draw the line at a handful of Sudafeds.
The questions asked in the editorial are:
"Firstly, should modafinil be considered a psychostimulant? Secondly, if it is a psychostimulant, and yet is required to treat a medical condition, should the athlete be disqualified? Thirdly, how should one verify the alleged medical diagnosis? Fourthly, what must the athlete do in order to maintain eligibility to compete when on a "banned substance?" Fifthly, should the punishments be specific or should they be tailored to specific situations? Sixthly, are we witnessing further doping scandals? "
http://bjsm.bmjjournals.com/cgi/content/full/39/4/241
This paragraph says it all though:
"The prevalence of narcolepsy is only 0.02–0.05% in the United States. To have an elite athlete with narcolepsy would be rare; however, when the 2003 US Track and Field Championship urines were retested, a total of six athletes were reported positive for modafinil during 2003. Although Kelli White is the only athlete to state that she has narcolepsy, it is not surprising that the IAAF has scoffed at "a narcolepsy epidemic.""
None one has Level 1 scientific evidence to prove that you run faster with stimulants on board, but whether or not you do, a large number of US Track & Field sprinters are prepared to run the gauntlet of the drug code to try to get on it.
Do we really need to get psychiatrists and sleep experts to come up with guidelines for the diagnosis of ADHD and narcolepsy in elite athletes or shouldn't we just say that all amphetamines are banned? Let's draw the line at a handful of Sudafeds.